Key facts
- TBD (Clinics/Outpatient Services)’s last known valuation is $1.3M (Jul 2021).
- It has raised $5.2M; the latest was Merger/Acquisition in Jan 2026.
- Status: Acquired/Merged (Operating Subsidiary).
- ·Watchlist + deal alerts for TBD (Clinics/Outpatient Services)
- ·The full record, as it builds
Funding rounds
No funding rounds for TBD (Clinics/Outpatient Services) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About TBD (Clinics/Outpatient Services)
Developer of a sexual health platform designed to provide STD/STI testing, telehealth consultations, and outpatient clinic services. The company offers at-home and in-clinic STD/STI tests, PrEP HIV prevention programs, contraceptive care, and telemedicine consultations, enabling clients to access diagnosis and treatment confidentially and conveniently.
- Sector
- Healthcare
- HQ
- Las Vegas, NV, United States
- Founded
- 2019
- Employees
- 10
- Website
- tbd.health/
- Ownership
- Acquired/Merged (Operating Subsidiary)
TBD (Clinics/Outpatient Services) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in TBD (Clinics/Outpatient Services) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on TBD (Clinics/Outpatient Services) in its N-PORT filings yet. We sweep new filings monthly.